Literature DB >> 11008015

Enhanced proteolysis of pre-mRNA splicing factors in myeloid cells.

Y Shav-Tal1, B Lee, S Bar-Haim, J Vandekerckhove, D Zipori.   

Abstract

OBJECTIVE: Molecular identification and characterization of the bone marrow nuclear protein detected by the B92 monoclonal antibody.
MATERIALS AND METHODS: The protein was purified to homogeneity from acute myeloid leukemia cells and was subjected to peptide digestion and amino acid sequencing. Identified sequences were used to screen a bone marrow cDNA library in search of matching transcripts. The protein was further studied in different cells and tissues by examination of protease inhibitors and harsh lytic conditions and during apoptosis in HL-60 cells.
RESULTS: We found that the apparent bone marrow specific protein is a 47 kD proteolytic cleavage product of PSF, an essential pre-mRNA splicing factor. PSF is completely cleaved to p47 during lysis of immature myeloid cells due to potent proteolytic activity found in these cells but is rare in other cells and tissues. Furthermore, p47 is abundant in intact normal and tumor myeloid cells while in other cell types it is undetectable. The cleavage of PSF is accompanied by digestion of the PTB splicing regulator but not other proteins tested. In contrast, during apoptosis PTB is degraded while PSF remains intact.
CONCLUSIONS: The bone marrow 47 kD protein is a fragment constituting the N-terminal, protease-resistant half of the splicing factor PSF. Proteolytic degradation of PSF specifically occurs in intact myeloid cells and this process is enhanced upon myeloid cell lysis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11008015     DOI: 10.1016/s0301-472x(00)00510-5

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  7 in total

1.  Nuclear relocalization of the pre-mRNA splicing factor PSF during apoptosis involves hyperphosphorylation, masking of antigenic epitopes, and changes in protein interactions.

Authors:  Y Shav-Tal; M Cohen; S Lapter; B Dye; J G Patton; J Vandekerckhove; D Zipori
Journal:  Mol Biol Cell       Date:  2001-08       Impact factor: 4.138

2.  Dynamic sorting of nuclear components into distinct nucleolar caps during transcriptional inhibition.

Authors:  Yaron Shav-Tal; Janna Blechman; Xavier Darzacq; Cristina Montagna; Billy T Dye; James G Patton; Robert H Singer; Dov Zipori
Journal:  Mol Biol Cell       Date:  2005-03-09       Impact factor: 4.138

3.  Nuclear cathepsin F regulates activation markers in rat hepatic stellate cells.

Authors:  Gunter Maubach; Michelle Chin Chia Lim; Lang Zhuo
Journal:  Mol Biol Cell       Date:  2008-07-30       Impact factor: 4.138

4.  The adapter protein Nck: role of individual SH3 and SH2 binding modules for protein interactions in T lymphocytes.

Authors:  Marcus Lettau; Jennifer Pieper; Alyn Gerneth; Beate Lengl-Janssen; Matthias Voss; Andreas Linkermann; Hendrik Schmidt; Christoph Gelhaus; Matthias Leippe; Dieter Kabelitz; Ottmar Janssen
Journal:  Protein Sci       Date:  2010-04       Impact factor: 6.725

Review 5.  PSF: nuclear busy-body or nuclear facilitator?

Authors:  Christopher A Yarosh; Joseph R Iacona; Carol S Lutz; Kristen W Lynch
Journal:  Wiley Interdiscip Rev RNA       Date:  2015-04-01       Impact factor: 9.957

6.  Novel marker for the onset of frontotemporal dementia: early increase in activity-dependent neuroprotective protein (ADNP) in the face of Tau mutation.

Authors:  Yulie Schirer; Anna Malishkevich; Yotam Ophir; Jada Lewis; Eliezer Giladi; Illana Gozes
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240

7.  Acute hepatotoxicity of 2' fluoro-modified 5-10-5 gapmer phosphorothioate oligonucleotides in mice correlates with intracellular protein binding and the loss of DBHS proteins.

Authors:  Wen Shen; Cheryl L De Hoyos; Hong Sun; Timothy A Vickers; Xue-Hai Liang; Stanley T Crooke
Journal:  Nucleic Acids Res       Date:  2018-03-16       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.